FILTRIX Logo FILTRIX Find Your Edge →

Latest signal:

CHRS Stock Analysis

Data source: Trade-Ideas Alerts | 47 alerts analyzed | Backtest period: 2022-01-12 → 2025-01-24

⚠️ Small sample size (47 alerts). Statistics may have high variance. Interpret with caution.

🏢 Company Profile

📍 NASDAQ 📅 IPO: Nov 06, 2014 🔗 www.coherus.com
💰 Market Cap: $249.0M 👥 Employees: 161
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
📊
47
Total Alerts
🎯
48.9%
Win Rate (60MIN)
💰
-0.62%
Avg Gain (60MIN)
🚀
+6.39%
Avg MFE (Max Potential)

📈 Performance by Timeframe

5MIN

Win Rate: 46.8%
Avg Gain: -0.37%
Avg Winner: +2.33%
Avg Loser: -2.76%
Best: +5.61%
Worst: -7.01%
Trades: 22/25

15MIN

Win Rate: 38.3%
Avg Gain: -0.80%
Avg Winner: +3.70%
Avg Loser: -3.73%
Best: +13.64%
Worst: -8.61%
Trades: 18/28

30MIN

Win Rate: 40.4%
Avg Gain: -0.36%
Avg Winner: +4.35%
Avg Loser: -3.69%
Best: +13.58%
Worst: -13.67%
Trades: 19/27

60MIN

Win Rate: 48.9%
Avg Gain: -0.62%
Avg Winner: +4.35%
Avg Loser: -5.61%
Best: +15.66%
Worst: -17.41%
Trades: 23/23

EOD (End of Day)

Win Rate: 36.2%
Avg Gain: -2.11%
Avg Winner: +7.24%
Avg Loser: -7.67%
Best: +22.26%
Worst: -22.33%
Trades: 17/29

🚀 Max Favorable / Adverse Excursion (MFE/MAE)

Institutional-grade metrics showing the maximum profit potential and risk for each alert.

📈 MFE (Max Profit Potential)

Average MFE: +6.39%
Best MFE: +25.65%
Avg Time to MFE: 84 min

On average, CHRS alerts reach +6.39% profit potential within 84 minutes.

📉 MAE (Max Drawdown Risk)

Average MAE: -2.85%
Worst MAE: -17.76%
Avg Time to MAE: 7 min

Before reaching MFE, expect an average drawdown of 2.85%.

⚖️ Risk/Reward Ratio

2.24:1

Excellent risk/reward - potential gain is 2.24x the typical drawdown.

💡 Trading Insight: Based on 47 alerts, CHRS typically reaches +6.39% profit before pulling back. Consider setting profit targets around 5.1% to capture most of the move.

🌅 Premarket Gap Analysis (9:25 → 9:30)

Total Gaps Analyzed 47
Gap Up % 38.3%
Avg Gap -0.22%
Best Gap +2.36%

🏭 Sector Comparison: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

How CHRS compares to 128 other tickers in the same sector.

5-Min Gain
CHRS: -0.37% Sector: -0.41% +0.04%
EOD Gain
CHRS: -2.11% Sector: +1233.50% -1235.62%
Avg MFE
CHRS: +6.39% Sector: +6.69% -0.30%

📋 Last 20 Alerts

Historical CHRS alerts with performance metrics calculated from 1-minute price data. Each row shows the actual price movement at different timeframes after the alert.

Date Time Price 5min 15min 30min 60min EOD MFE MAE Gap Result
2025-01-24 09:26:17 $1.36 -1.84% -2.21% -1.10% +0.10% -8.82% +1.51% -3.67% -1.47% LOSS
2024-12-10 09:29:20 $1.72 -1.08% -1.74% -0.29% -2.03% -6.40% - -2.33% -1.16% LOSS
2024-12-09 09:28:29 $1.76 +0.56% +0.67% +1.99% +2.84% -3.41% +5.11% -3.41% +1.14% WIN
2024-12-06 09:28:16 $1.52 -1.32% +0.33% +2.96% +2.96% +11.84% +14.47% -4.61% -1.97% LOSS
2024-12-05 09:26:44 $1.8 -3.06% -3.06% -3.89% -5.83% -16.11% - - - LOSS
2024-12-04 09:27:18 $1.78 +5.61% - -0.28% - -3.93% +9.55% -4.78% +2.25% WIN
2024-12-03 09:25:53 $2.14 -7.01% -1.87% +9.81% -6.50% -20.09% +13.55% -17.76% -4.67% LOSS
2024-11-21 09:25:49 $1.07 +1.87% -3.93% -3.74% +0.92% +2.80% +9.35% -5.61% - WIN
2024-11-08 09:26:59 $0.82 +2.67% -2.57% -2.73% -2.40% -0.54% +4.94% +1.29% +1.29% WIN
2024-11-07 09:27:40 $0.78 +5.23% +4.08% +7.49% +10.20% +4.59% +21.81% -2.93% +1.52% WIN
2024-10-04 09:27:05 $1.0 +2.00% -1.89% -1.11% +3.00% +4.00% +8.00% -1.98% -1.00% WIN
2024-10-03 09:29:40 $1.05 -3.80% -3.71% +7.62% +3.81% -0.95% +17.14% -3.81% -2.86% LOSS
2024-06-27 09:29:42 $1.69 +1.48% +3.56% +1.48% +2.01% +0.59% +4.14% -1.18% +0.59% WIN
2024-03-04 09:29:38 $2.56 -6.25% -7.43% -9.18% -11.13% -11.33% -0.78% -5.86% -0.78% LOSS
2024-02-20 09:25:08 $2.68 +0.37% +0.41% +1.49% +3.17% -3.36% +3.73% -0.37% - WIN
2024-02-13 09:27:34 $2.54 +2.76% +4.33% +2.76% +3.35% +0.79% +5.88% -1.57% +2.36% WIN
2023-12-29 09:28:00 $3.33 +0.30% -2.70% -2.23% -3.00% - +2.40% -5.71% -0.60% WIN
2023-12-28 09:28:00 $2.65 +3.24% +11.13% +13.58% +15.66% +22.26% +25.65% -3.02% - WIN
2023-12-27 09:25:00 $2.96 -0.67% -7.94% -8.10% -9.63% -9.12% +3.04% -3.04% +1.35% LOSS
2023-12-08 09:28:00 $2.15 -2.83% +1.16% +2.09% +3.95% +3.26% +6.98% -4.18% +0.47% LOSS

Table Metrics Explained:

  • 5min/15min/30min/60min/EOD: Price change at each timeframe (calculated from real minute-by-minute data)
  • MFE: Maximum Favorable Excursion - highest profit potential reached during the day
  • MAE: Maximum Adverse Excursion - worst drawdown experienced before reaching MFE
  • Gap: Premarket price gap from 9:25 AM to 9:30 AM market open
  • Result: WIN if 5min change > 0%, LOSS otherwise

⚠️ CHRS Shows Negative Expectancy

With 48.9% win rate and -0.62% average gain, CHRS alerts have historically faded. Use the app to find specific filters that might reverse this pattern, or consider CHRS for short-selling strategies.

📉 Turn Negative Expectancy Positive →

Why Analyze CHRS with FILTRIX?

🛡️ Realistic Entry Simulation

We don't inflate stats. Our analysis tracks only the first alert of the day for CHRS. This simulates a true "Gap & Go" entry at pre-market hours (9:25-9:30 AM), avoiding the trap of chasing a stock that has already extended.

💰 Max Potential (MFE) Analysis

How much is left in the move? On winning days, CHRS historically offers an average upside of +6.39% intraday. Our data helps you distinguish between a quick scalp and a runner.

📊 CHRS Momentum Personality

With a baseline win rate of 48.9%, CHRS shows negative momentum - the stock tends to fade after alerts. This pattern suggests CHRS may be better suited for contrarian strategies or avoiding altogether.

⏱️ Optimized Exit Timing

⚠️ Caution Advised: CHRS shows negative expectancy across all tested intraday timeframes (Best: 60MIN at -0.62%). This suggests CHRS is prone to fading after the open, making it a potential candidate for short-selling or quick scalps only.